Pravastatin Administration Alleviates Kanamycin-Induced Cochlear Injury and Hearing Loss.

Int J Mol Sci

Department of Otorhinolaryngology-Head & Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea.

Published: April 2022

AI Article Synopsis

  • Statins, like pravastatin (PV), have a debated role in protecting against hearing loss caused by aminoglycoside drugs, specifically kanamycin (KM).
  • In the study, adult rats were treated with KM, and some received PV, allowing researchers to measure changes in hearing using auditory brainstem response (ABR) thresholds.
  • Results showed that while KM increased ABR thresholds (indicating hearing loss), the combination of PV and KM resulted in improved thresholds and better preservation of cochlear cells, suggesting PV's protective role against KM-induced hearing loss through regulating cellular processes like autophagy and apoptosis.

Article Abstract

The effect of statins on aminoglycoside-induced ototoxicity is controversial. This study aimed to explore the role of pravastatin (PV) in kanamycin-induced hearing loss in rats. Adult rats were intraperitoneally treated with 20 mg/kg/day of kanamycin (KM) for 10 days. In the PV- and PV + KM-treated rats, 25 mg/kg/day of PV was intraperitoneally administered for 5 days. The auditory brainstem response (ABR) thresholds were measured before and after drug treatment using a smartEP system at 4, 8, 16, and 32 kHz. Cochlear changes in poly ADP-ribose (PAR) polymerase (PARP), PAR, and caspase 3 were estimated using Western blotting. PV administration did not increase the ABR thresholds. The KM-treated rats showed elevated ABR thresholds at 4, 8, 16, and 32 kHz. The PV + KM-treated rats demonstrated lower ABR thresholds than the KM-treated rats at 4, 8, and 16 kHz. The cochlear outer hair cells and spiral ganglion cells were relatively preserved in the PV + KM-treated rats when compared with that in the KM-treated rats. The cochlear expression levels of PARP, PAR, and caspase 3 were higher in the KM-treated rats. The PV + KM-treated rats showed lower levels of PARP, PAR, and caspase 3 than the KM-treated rats. PV protected cochleae from KM-induced hearing loss in rats. The regulation of autophagy and apoptosis mediated the otoprotective effects of PV.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105065PMC
http://dx.doi.org/10.3390/ijms23094524DOI Listing

Publication Analysis

Top Keywords

km-treated rats
36
abr thresholds
16
hearing loss
12
rats
12
parp par
12
par caspase
12
km-treated
9
loss rats
8
khz cochlear
8
thresholds km-treated
8

Similar Publications

Pravastatin Administration Alleviates Kanamycin-Induced Cochlear Injury and Hearing Loss.

Int J Mol Sci

April 2022

Department of Otorhinolaryngology-Head & Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea.

Article Synopsis
  • Statins, like pravastatin (PV), have a debated role in protecting against hearing loss caused by aminoglycoside drugs, specifically kanamycin (KM).
  • In the study, adult rats were treated with KM, and some received PV, allowing researchers to measure changes in hearing using auditory brainstem response (ABR) thresholds.
  • Results showed that while KM increased ABR thresholds (indicating hearing loss), the combination of PV and KM resulted in improved thresholds and better preservation of cochlear cells, suggesting PV's protective role against KM-induced hearing loss through regulating cellular processes like autophagy and apoptosis.
View Article and Find Full Text PDF

Background: Flavonoids have previously been suggested to play a role in wound healing. To date, however, limited information is available on the wound healing effect of kaempferol (KM), which belongs to the class of flavonoids. The objective of this study was to determine the wound healing effects of KM.

View Article and Find Full Text PDF

[Morphologic studies of the protective role of catechin on kanamycin otoneurotoxicity in SD rats].

Hunan Yi Ke Da Xue Xue Bao

December 2002

Department of Otorhinolaryngology, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Objective: To determine the protection of catechin on aminoglycoside antibiotics otoneurotoxicity in SD rats, and observe the morphologic changes of cochlear efferent nerve terminals and outer hair cells after the injection of kanamycin and the feeding of catechin by the stomach tube.

Methods: Thirty-eight SD rats were randomly assigned into three experimental groups (KM-treated, catechin-treated, KM and catechin in combination) and one control group. The KM-treated group was given kanamycin in a dose of 500 mg.

View Article and Find Full Text PDF

Fos-immunoreactive responses in inferior colliculi of rats with experimental audiogenic seizure susceptibility.

Epilepsy Res

May 1997

Gordon and Mary Cain Pediatric Neurology Research Institute, Texas Children's Hospital (MC-3-6365), Baylor College of Medicine, Houston 77030, USA.

Audiogenic seizure (AGS) susceptibility is a reflex epilepsy of rodents in which acoustic stimulation evokes wild running attacks and subsequent convulsions. Susceptibility can be induced in non-susceptible strains by treatments causing transient or permanent hearing losses as long as these occur during the neonatal period. The defect which is the basis of susceptibility has been proposed to be a failure of developmental organization of inferior colliculus (IC) into frequency selective zones.

View Article and Find Full Text PDF

Cochlear integrity in rats with experimentally induced audiogenic seizure susceptibility.

Hear Res

November 1996

Cain Foundation Laboratories, Texas Children's Hospital (MC-3-6365), Baylor College of Medicine, Houston 77030, USA.

While chronic susceptibility of rodents to audiogenic seizures (AGSs) is often accompanied by cochlear lesions, it has not been demonstrated whether cochlear hair cell losses are essential to pathogenesis in this epileptic disorder. An alternative possibility is that the neonatal timing of hearing losses is what unites various models of chronic AGS susceptibility. In the latter case, either transient or permanent hearing losses might induce susceptibility as long as they concur with a critical period of development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!